STOCK TITAN

AVTR Form 144: Restricted Stock Vesting and Proposed Insider Sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form: Form 144 notice relating to Avantor, Inc. (Issuer stated: Avantor Inc).

Transaction: Proposed sale of 3,476 common shares through Merrill (address: 8890 Lyra Drive 5th Floor Columbus OH 43240) with an aggregate market value of $39,592.00. Approximate sale date is 08/05/2025 on the NYSE. Total shares outstanding reported: 681,738,675.

Acquisition: 1,033 shares were acquired via a Restricted Stock Grant Vest from Avantor Inc on 07/31/2025 with payment dated 07/31/2025. The filer reports Nothing to Report for securities sold in the past three months. Several filer identification/contact fields (e.g., CIK) are blank in the provided extract.

Positive

  • Rule 144 disclosure submitted detailing broker, class, quantity, value, and expected sale date
  • No securities sold in the past three months reported for the selling person

Negative

  • Filer identification/contact fields are blank in the provided extract (e.g., CIK not shown)
  • Sale size is small relative to outstanding shares (3,476 vs. 681,738,675), indicating immateriality to capitalization

Insights

TL;DR: Routine Rule 144 disclosure for a small proposed sale; no earnings or guidance impact evident.

The Form 144 reports a proposed sale of 3,476 common shares valued at $39,592, with an approximate sale date of 08/05/2025 on the NYSE. The filing includes acquisition details showing 1,033 shares vested from a restricted stock grant on 07/31/2025. Given the issuer's reported 681,738,675 shares outstanding, the sale size is immaterial to capital structure and does not present a quantifiable impact on revenue, EPS, or market capitalization from the information provided.

TL;DR: Compliance filing completed, but certain filer identification fields are missing in the extract provided.

The notice satisfies Rule 144 disclosure by listing broker, class, quantities, acquisition method, and approximate sale date. The filing extract lacks visible filer CIK and submission contact details, which are typically required for full traceability and regulatory cross-reference. The document also states Nothing to Report for prior three-month sales, which clarifies recent activity. From a governance/compliance view, the missing filer identifiers in this extract warrant completion for full regulatory compliance verification.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Avantor (AVTR) report in this Form 144?

The filing reports a proposed sale of 3,476 common shares valued at $39,592.00, with an approximate sale date of 08/05/2025 on the NYSE.

Who is the broker handling the proposed sale for AVTR?

The broker listed is Merrill at address 8890 Lyra Drive 5th Floor Columbus OH 43240.

When and how were the securities acquired for this AVTR sale?

A portion (1,033 shares) was acquired via a Restricted Stock Grant Vest from Avantor Inc on 07/31/2025, with payment dated 07/31/2025.

Does the filing show any sales in the past three months for the seller?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

How large is the proposed sale relative to Avantor's outstanding shares?

The filing reports 681,738,675 shares outstanding; the proposed sale of 3,476 shares is therefore a very small fraction of outstanding equity.

Are any filer identification details missing from the provided extract?

Yes, key filer identification/contact fields such as the Filer CIK are not shown in the provided extract.
Avantor

NYSE:AVTR

View AVTR Stock Overview

AVTR Rankings

AVTR Latest News

AVTR Latest SEC Filings

AVTR Stock Data

5.19B
656.41M
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States
RADNOR